Announcement on Convening the 2024 Semi-annual Performance Briefing
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
View Attachment
Announcement on Convening the 2024 Semi-annual Performance Briefing
Filed with SSE ·
6ix hasn’t read this filing yet.
Hangzhou Tianmushan Pharmaceutical Enterprise Co Ltd on 6ix
Earlier from Hangzhou Tianmushan Pharmaceutical Enterprise
Later from Hangzhou Tianmushan Pharmaceutical Enterprise
- Announcement on Renewing Engagement of Accounting Firm
- Announcement on Resolutions of the 5th Extraordinary General Meeting in 2024
- Report for Q3 2024
- Announcement on Abnormal Fluctuations in Stock Trading and Risk Alert
- Announcement on the Renewal of the Drug Distribution License of Holding Subsidiary
Follow Hangzhou Tianmushan Pharmaceutical Enterprise into a list and get an email when it puts out news.
Follow Hangzhou Tianmushan Pharmaceutical Enterprise